


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app41.us.archive.org';v.server_ms=1189;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>ACR Appropriateness Criteria&amp;reg; acute pelvic pain in the reproductive age group. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712204238im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712204238im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712204238im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712204238im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712204238/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712204238im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712204238cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712204238js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712204238if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712204238/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712204238if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712204238/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712204238/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712204238/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712204238/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712204238im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712204238im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712204238im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712204238/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712204238/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712204238/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712204238/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712204238/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712204238/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712204238/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712204238/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712204238/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712204238/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712204238/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712204238/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712204238/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712204238/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712204238/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712204238/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712204238/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712204238/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712204238/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712204238/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712204238/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:010847</li>
            <li>2015
            </li>            
                                </ul>
        <div>
                <h1>ACR Appropriateness Criteria&reg; acute pelvic pain in the reproductive age group.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712204238/https://www.guideline.gov/search?f_Guideline_Developer_String=American%20College%20of%20Radiology&amp;fLockTerm=American%2BCollege%2Bof%2BRadiology">American College of Radiology</a></li>
                        <li>   
                                <a id="246" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Bhosale PR, Atri M, Harris RD, Kang SK, Meyer BJ, Pandharipande PV, Reinhold C, Salazar GM, Shipp TD, Simpson L, Sussman BL, Uyeda J, Wall DJ, Zelop CM, Javitt MC, Glanc P, Expert Panel on Women’s Imaging. ACR Appropriateness Criteria® acute pelvic pain in the reproductive age group. Reston (VA): American College of Radiology (ACR); 2015. 13 p.  [91 references]</td></tr></table>                    <p><a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=fulltextlink&amp;redirect=https%253a%252f%252facsearch.acr.org%252fdocs%252f69503%252fNarrative">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Andreotti RF, Lee SI, DeJesus Allison SO, Bennett GL, Brown DL, Dubinsky T, Glanc P, Javitt MC, Mitchell DG, Podrasky AE, Shipp TD, Siegel CL, Wong-You-Cheong JJ, Zelop CM, Expert Panel on Women's Imaging. ACR Appropriateness Criteria&reg; acute pelvic pain in the reproductive age group. [online publication]. Reston (VA): American College of Radiology (ACR); 2011. 8 p. [51 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180712204238/https://www.guideline.gov/search?f_Age_of_Target_Population=Adolescent%20%2813%20to%2018%20years%29&amp;fLockTerm=Adolescent%2B%2813%2Bto%2B18%2Byears%29">Adolescent (13 to 18 years)</a></li>                      
                        <li><a href="/web/20180712204238/https://www.guideline.gov/search?f_Age_of_Target_Population=Adult%20%2819%20to%2044%20years%29&amp;fLockTerm=Adult%2B%2819%2Bto%2B44%2Byears%29">Adult (19 to 44 years)</a></li>                      
                        <li><a href="/web/20180712204238/https://www.guideline.gov/search?f_Age_of_Target_Population=Middle%20Age%20%2845%20to%2064%20years%29&amp;fLockTerm=Middle%2BAge%2B%2845%2Bto%2B64%2Byears%29">Middle Age (45 to 64 years)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180712204238/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712204238/https://www.guideline.gov/search?f_ICD9CM_CUI=C0011923&amp;fLockTerm=Diagnostic+imaging%2c+not+elsewhere+classified">Diagnostic imaging, not elsewhere classified</a>
 (88.90), <a href="/web/20180712204238/https://www.guideline.gov/search?f_ICD9CM_CUI=C0242172&amp;fLockTerm=Unspecified+inflammatory+disease+of+female+pelvic+organs+and+tissues">Unspecified inflammatory disease of female pelvic organs and tissues</a>
 (614.9)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0001314&amp;fLockTerm=Acute+Disease">Acute Disease</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0106132&amp;fLockTerm=Chorionic+Gonadotropin%2c+beta+Subunit%2c+Human">Chorionic Gonadotropin, beta Subunit, Human</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0011906&amp;fLockTerm=Diagnosis%2c+Differential">Diagnosis, Differential</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0011923&amp;fLockTerm=Diagnostic+Imaging">Diagnostic Imaging</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0024485&amp;fLockTerm=Magnetic+Resonance+Imaging">Magnetic Resonance Imaging</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0242172&amp;fLockTerm=Pelvic+Inflammatory+Disease">Pelvic Inflammatory Disease</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0030794&amp;fLockTerm=Pelvic+Pain">Pelvic Pain</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0032976&amp;fLockTerm=Pregnancy+Tests">Pregnancy Tests</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0032987&amp;fLockTerm=Pregnancy%2c+Ectopic">Pregnancy, Ectopic</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0936234&amp;fLockTerm=Tomography+Scanners%2c+X-Ray+Computed">Tomography Scanners, X-Ray Computed</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0040405&amp;fLockTerm=Tomography%2c+X-Ray+Computed">Tomography, X-Ray Computed</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MSH_CUI=C0242845&amp;fLockTerm=Ultrasonography%2c+Doppler%2c+Duplex">Ultrasonography, Doppler, Duplex</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0106132&amp;fLockTerm=Chorionic+Gonadotropin%2c+beta+Subunit%2c+Human">Chorionic Gonadotropin, beta Subunit, Human</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0936234&amp;fLockTerm=Computed+Tomography+Scanning+Systems">Computed Tomography Scanning Systems</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0011923&amp;fLockTerm=Diagnostic+Imaging">Diagnostic Imaging</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0043299&amp;fLockTerm=Diagnostic+radiologic+examination">Diagnostic radiologic examination</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0011906&amp;fLockTerm=Differential+Diagnosis">Differential Diagnosis</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0032987&amp;fLockTerm=Ectopic+Pregnancy">Ectopic Pregnancy</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0024485&amp;fLockTerm=Magnetic+Resonance+Imaging">Magnetic Resonance Imaging</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0242172&amp;fLockTerm=Pelvic+Inflammatory+Disease">Pelvic Inflammatory Disease</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0030794&amp;fLockTerm=Pelvic+Pain">Pelvic Pain</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0032976&amp;fLockTerm=Pregnancy+Tests">Pregnancy Tests</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C2348813&amp;fLockTerm=Transabdominal+Ultrasound">Transabdominal Ultrasound</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_MTH_CUI=C0040405&amp;fLockTerm=X-Ray+Computed+Tomography">X-Ray Computed Tomography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712204238/https://www.guideline.gov/search?f_PDQ_CUI=C0040405&amp;fLockTerm=computed+tomography">computed tomography</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_PDQ_CUI=C0011923&amp;fLockTerm=diagnostic+imaging">diagnostic imaging</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_PDQ_CUI=C0043299&amp;fLockTerm=diagnostic+radiology">diagnostic radiology</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_PDQ_CUI=C0024485&amp;fLockTerm=magnetic+resonance+imaging">magnetic resonance imaging</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_PDQ_CUI=C0041618&amp;fLockTerm=ultrasonography">ultrasonography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0001314&amp;fLockTerm=Acute+disease">Acute disease</a>
 (2704003), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1282322&amp;fLockTerm=Acute+pelvic+pain">Acute pelvic pain</a>
 (314716005), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0040405&amp;fLockTerm=Computerized+axial+tomography">Computerized axial tomography</a>
 (77477000), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009924&amp;fLockTerm=Contrast+media">Contrast media</a>
 (385420005), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009924&amp;fLockTerm=Contrast+media">Contrast media</a>
 (407935004), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011906&amp;fLockTerm=Differential+diagnosis">Differential diagnosis</a>
 (47965005), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0242845&amp;fLockTerm=Duplex+ultrasound">Duplex ultrasound</a>
 (312236008), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032987&amp;fLockTerm=Ectopic+pregnancy">Ectopic pregnancy</a>
 (34801009), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0242172&amp;fLockTerm=Female+pelvic+inflammatory+disease">Female pelvic inflammatory disease</a>
 (198130006), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0106132&amp;fLockTerm=Human+chorionic+gonadotropin%2c+beta+subunit">Human chorionic gonadotropin, beta subunit</a>
 (40940006), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011923&amp;fLockTerm=Imaging">Imaging</a>
 (363679005), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0024485&amp;fLockTerm=Magnetic+resonance+imaging">Magnetic resonance imaging</a>
 (113091000), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0024485&amp;fLockTerm=Magnetic+resonance+imaging">Magnetic resonance imaging</a>
 (312250003), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0336660&amp;fLockTerm=Magnetic+resonance+imaging+unit">Magnetic resonance imaging unit</a>
 (90003000), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0030794&amp;fLockTerm=Pain+in+pelvis">Pain in pelvis</a>
 (30473006), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
 (289908002), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032976&amp;fLockTerm=Pregnancy+detection+examination">Pregnancy detection examination</a>
 (74036000), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0430060&amp;fLockTerm=Serum+pregnancy+test+(B-HCG)">Serum pregnancy test (B-HCG)</a>
 (166434005), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C2315532&amp;fLockTerm=Transvaginal+ultrasonography+of+pelvis">Transvaginal ultrasonography of pelvis</a>
 (429915000), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
 (16310003), <a href="/web/20180712204238/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
 (278292003)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SPN</h5>
                    <div class="field-content">
<a href="/web/20180712204238/https://www.guideline.gov/search?f_SPN_CUI=C0183135&amp;fLockTerm=IMAGER%2c+ULTRASONIC+OBSTETRIC-GYNECOLOGIC">IMAGER, ULTRASONIC OBSTETRIC-GYNECOLOGIC</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_SPN_CUI=C0302622&amp;fLockTerm=SYSTEM%2c+IMAGING%2c+PULSED+DOPPLER%2c+ULTRASONIC">SYSTEM, IMAGING, PULSED DOPPLER, ULTRASONIC</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_SPN_CUI=C0336660&amp;fLockTerm=SYSTEM%2c+NUCLEAR+MAGNETIC+RESONANCE+IMAGING">SYSTEM, NUCLEAR MAGNETIC RESONANCE IMAGING</a>
, <a href="/web/20180712204238/https://www.guideline.gov/search?f_SPN_CUI=C0936234&amp;fLockTerm=SYSTEM%2c+X-RAY%2c+TOMOGRAPHY%2c+COMPUTED">SYSTEM, X-RAY, TOMOGRAPHY, COMPUTED</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180712204238/https://www.guideline.gov/search?f_UMD_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
 (16-573), <a href="/web/20180712204238/https://www.guideline.gov/search?f_UMD_CUI=C0936234&amp;fLockTerm=Scanning+Systems%2c+Computed+Tomography">Scanning Systems, Computed Tomography</a>
 (13-469), <a href="/web/20180712204238/https://www.guideline.gov/search?f_UMD_CUI=C0336660&amp;fLockTerm=Scanning+Systems%2c+Magnetic+Resonance+Imaging">Scanning Systems, Magnetic Resonance Imaging</a>
 (16-260), <a href="/web/20180712204238/https://www.guideline.gov/search?f_UMD_CUI=C0302622&amp;fLockTerm=Scanning+Systems%2c+Ultrasonic">Scanning Systems, Ultrasonic</a>
 (14-278), <a href="/web/20180712204238/https://www.guideline.gov/search?f_UMD_CUI=C0183135&amp;fLockTerm=Scanning+Systems%2c+Ultrasonic%2c+Obstetric%2fGynecologic">Scanning Systems, Ultrasonic, Obstetric/Gynecologic</a>
 (15-657)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712204238/https://www.guideline.gov/summaries/downloadcontent/ngc-10847?contentType=pdf" class="pdf">.PDF 132.8 kb</a></li>
                            <li><a href="/web/20180712204238/https://www.guideline.gov/summaries/downloadcontent/ngc-10847?contentType=word" class="word">Word Document 351.9 kb</a></li>
                            <li><a href="/web/20180712204238/https://www.guideline.gov/summaries/downloadcontent/ngc-10847?contentType=xml" class="xml">.XML 95.4 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712204238/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/49922/acr-appropriateness-criteria--acute-pelvic-pain-in-the-reproductive-age-group" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712204238/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/49922/acr-appropriateness-criteria--acute-pelvic-pain-in-the-reproductive-age-group" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712204238/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/49922/acr-appropriateness-criteria--acute-pelvic-pain-in-the-reproductive-age-group&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712204238/mailto:/?Subject=AHRQ: ACR Appropriateness Criteria&amp;amp;reg; acute pelvic pain in the reproductive age group.&amp;body=https://www.guideline.gov/summaries/summary/49922/acr-appropriateness-criteria--acute-pelvic-pain-in-the-reproductive-age-group" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: ACR Appropriateness Criteria&reg; acute pelvic pain in the reproductive age group. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2015 Jan 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712204238/https://www.guideline.gov/summaries/citedownload/49922?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712204238/https://www.guideline.gov/summaries/citedownload/49922?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712204238/https://www.guideline.gov/summaries/citedownload/49922?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712204238/https://www.guideline.gov/summaries/citedownload/49922?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712204238/https://www.guideline.gov/summaries/citedownload/49922?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712204238/https://www.guideline.gov/summaries/citedownload/49922">RefWorks</a></li>
                            <li><a href="/web/20180712204238/https://www.guideline.gov/summaries/citedownload/49922?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="49922" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>ACR Appropriateness Criteria&reg;</strong></p>
<p><strong><span style="text-decoration: underline;">Clinical Condition</span>: Acute Pelvic Pain in the Reproductive Age Group</strong></p>
<p><strong><span style="text-decoration: underline;">Variant 1</span>: Gynecological etiology suspected, serum &beta;-hCG positive.</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 1: Gynecological etiology suspected, serum beta-hCG positive.">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="20%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">US pelvis transvaginal</td>
            <td class="Center" valign="middle">9</td>
            <td valign="top">Both transvaginal and transabdominal US should be performed if possible.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">US pelvis transabdominal</td>
            <td class="Center" valign="middle">9</td>
            <td valign="top">Both transvaginal and transabdominal US should be performed if possible.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">US duplex Doppler adnexa</td>
            <td class="Center" valign="middle">8</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">MRI pelvis without contrast</td>
            <td class="Center" valign="middle">6</td>
            <td valign="top">This procedure can be performed if US is inconclusive or nondiagnostic. See the Summary of Literature Review below and <em>ACR Manual on Contrast Media</em> (see the "Availability of Companion Documents" field) for use of contrast media.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">MRI abdomen and pelvis without contrast</td>
            <td class="Center" valign="middle">6</td>
            <td valign="top">This procedure can be performed if US is inconclusive or nondiagnostic. See the Summary of Literature Review below and <em>ACR Manual on Contrast Media</em> (see the "Availability of Companion Documents" field) for use of contrast media.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">MRI pelvis without and with contrast</td>
            <td class="Center" valign="middle">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">MRI abdomen and pelvis without and with contrast</td>
            <td class="Center" valign="middle">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">CT pelvis without contrast</td>
            <td class="Center" valign="middle">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT pelvis with contrast</td>
            <td class="Center" valign="middle">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT pelvis without and with contrast</td>
            <td class="Center" valign="middle">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis without contrast</td>
            <td class="Center" valign="middle">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis with contrast</td>
            <td class="Center" valign="middle">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis without and with contrast</td>
            <td class="Center" valign="middle">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 2</span>: Gynecological etiology suspected, serum &beta;-hCG negative.</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 2: Gynecological etiology suspected, serum beta-hCG negative.">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="20%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">US pelvis transvaginal</td>
            <td class="Center" valign="middle">9</td>
            <td valign="top">Both transvaginal and transabdominal US should be performed if possible.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">US pelvis transabdominal</td>
            <td class="Center" valign="middle">9</td>
            <td valign="top">Both transvaginal and transabdominal US should be performed if possible.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">US duplex Doppler pelvis</td>
            <td class="Center" valign="middle">9</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">MRI pelvis without and with contrast</td>
            <td class="Center" valign="middle">6</td>
            <td valign="top">This procedure can be performed if US is inconclusive or nondiagnostic. See the Summary of Literature Review below and <em>ACR Manual on Contrast Media</em> (see the "Availability of Companion Documents" field) for the use of contrast media.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">MRI abdomen and pelvis without and with contrast</td>
            <td class="Center" valign="middle">6</td>
            <td valign="top">This procedure can be performed if US is inconclusive or nondiagnostic. See the Summary of Literature Review below and <em>ACR Manual on Contrast Media</em> (see the "Availability of Companion Documents" field) for the use of contrast media.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">MRI pelvis without contrast</td>
            <td class="Center" valign="middle">4</td>
            <td valign="top">This procedure can be performed if US is inconclusive or nondiagnostic. See the Summary of Literature Review below and <em>ACR Manual on Contrast Media</em> (see the "Availability of Companion Documents" field) for the use of contrast media.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">MRI abdomen and pelvis without contrast</td>
            <td class="Center" valign="middle">4</td>
            <td valign="top">This procedure can be performed if US is inconclusive or nondiagnostic. See the Summary of Literature Review below and <em>ACR Manual on Contrast Media</em> (see the "Availability of Companion Documents" field) for the use of contrast media.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis with contrast</td>
            <td class="Center" valign="middle">4</td>
            <td valign="top">This procedure can be performed if US is inconclusive or nondiagnostic and MRI is not available. See the Summary of Literature Review below for the use of contrast media.</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT pelvis with contrast</td>
            <td class="Center" valign="middle">4</td>
            <td valign="top">This procedure can be performed if US is inconclusive or nondiagnostic and MRI is not available. In young women undergoing repeat imaging, the cumulative radiation dose should be considered. See the Summary of Literature Review below for the use of contrast media.</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT pelvis without contrast</td>
            <td class="Center" valign="middle">2</td>
            <td valign="top">This procedure can be performed if US is inconclusive or nondiagnostic and MRI is not available. In young women undergoing repeat imaging, cumulative radiation dose should be considered.</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT pelvis without and with contrast</td>
            <td class="Center" valign="middle">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis without contrast</td>
            <td class="Center" valign="middle">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis without and with contrast</td>
            <td class="Center" valign="middle">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 3</span>: Nongynecological etiology suspected, serum &beta;-hCG positive.</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 3:  Nongynecological etiology suspected, serum beta-hCG positive.">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="20%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">US pelvis transvaginal</td>
            <td class="Center" valign="middle">9</td>
            <td valign="top">This procedure is usually performed in conjunction with transabdominal US.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">US abdomen and pelvis transabdominal</td>
            <td class="Center" valign="middle">9</td>
            <td valign="top">Add transvaginal US as indicated. </td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">US duplex Doppler adnexa </td>
            <td class="Center" valign="middle">8</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">MRI abdomen and pelvis without contrast</td>
            <td class="Center" valign="middle">8</td>
            <td valign="top">See the Summary of Literature Review below and <em>ACR Manual on Contrast Media</em> (see the "Availability of Companion Documents" field) for use of contrast media.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis with contrast</td>
            <td class="Center" valign="middle">4</td>
            <td valign="top">This procedure can be performed if US is nondiagnostic and MRI is unavailable or equivocal or for prompt diagnosis of a potentially life-threatening condition. See the Summary of Literature Review below for the use of contrast media.</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis without contrast</td>
            <td class="Center" valign="middle">3</td>
            <td valign="top">Literature suggests that noncontrast low-dose CT is better than US for diagnosing appendicitis, diverticulitis, enteritis, and renal calculi.</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">MRI abdomen and pelvis without and with contrast</td>
            <td class="Center" valign="middle">2</td>
            <td valign="top">See the Summary of Literature Review below and <em>ACR Manual on Contrast Media</em> (see the "Availability of Companion Documents" field) for the use of contrast media.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis without and with contrast</td>
            <td class="Center" valign="middle">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 4</span>: Nongynecological etiology suspected, serum &beta;-hCG negative.</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 4: Nongynecological etiology suspected, serum beta-hCG negative.">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="20%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">CT abdomen and pelvis with contrast</td>
            <td class="Center" valign="middle">9</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">US abdomen and pelvis transabdominal</td>
            <td class="Center" valign="middle">7</td>
            <td valign="top">This procedure can be appropriate for suspected appendicitis and urinary tract pathology and to minimize radiation exposure.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">US duplex Doppler pelvis</td>
            <td class="Center" valign="middle">7</td>
            <td valign="top">Doppler can be used as an adjunct to assess for appendicitis or to evaluate ureteral jets for obstructive versus nonobstructive pathology.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis without contrast</td>
            <td class="Center" valign="middle">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">MRI abdomen and pelvis without and with contrast</td>
            <td class="Center" valign="middle">6</td>
            <td valign="top">This procedure can be used to avoid the radiation exposure of CT in a young patient or if US is inconclusive or nondiagnostic. See the Summary of Literature Review below and <em>ACR Manual on Contrast Media</em> (see the "Availability of Companion Documents" field) for the use of contrast media.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">MRI abdomen and pelvis without contrast</td>
            <td class="Center" valign="middle">4</td>
            <td valign="top">This procedure can be used to avoid the radiation exposure of CT in a young patient or if US is inconclusive or nondiagnostic. See the Summary of Literature Review below and <em>ACR Manual on Contrast Media</em> (see the "Availability of Companion Documents" field) for the use of contrast media.</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">US pelvis transvaginal</td>
            <td class="Center" valign="middle">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle">O</td>
        </tr>
        <tr>
            <td valign="top">CT abdomen and pelvis without and with contrast</td>
            <td class="Center" valign="middle">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="middle"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Summary of Literature Review</span></strong></p>
<p><strong>Introduction/Background</strong></p>
<p>Premenopausal women with acute pelvic pain often pose a diagnostic dilemma. They often exhibit nonspecific signs and symptoms, the most common being nausea, vomiting, and leukocytosis. The differential considerations encompass gynecologic and obstetrical causes (e.g., hemorrhagic ovarian cysts, pelvic inflammatory disease, ovarian torsion, ectopic pregnancy, spontaneous abortion, or labor and placental abruption), as well as nongynecologic etiologies (e.g., appendicitis, inflammatory bowel disease, infectious enteritis, diverticulitis, urinary tract calculi, pyelonephritis, and pelvic thrombophlebitis). The choice of imaging modality is determined by the most likely clinically suspected differential diagnosis. Thus, a thorough clinical evaluation of the patient is required to determine the index of suspicion among the various etiologies. Diagnostic considerations should be based upon correlation of history, physical examination, and laboratory testing before a radiologic examination is chosen.</p>
<p>Transvaginal (TVS) and transabdominal (TAS) pelvic sonography is the preferred imaging modality for initial assessment when an obstetrical or gynecologic etiology is suspected due to its wide availability, lack of ionizing radiation, and diagnostic versatility. Computed tomography (CT) is more useful when gastrointestinal or urinary tract pathology is likely. Magnetic resonance imaging (MRI), with its lack of ionizing radiation and excellent soft-tissue contrast, is preferred over CT for assessing the pregnant patient for nongynecologic pathologies; however, it is hampered by lack of widespread availability, especially in the acute setting.</p>
<p><strong>Serum &beta;-Human Chorionic Gonadotropin (&beta;-hCG)</strong></p>
<p>A serum &beta;-hCG test is usually performed when a menstruating female presents with symptoms of acute pelvic pain. Knowledge of pregnancy is of utmost importance to determine whether pregnancy-related causes of pain should be considered, especially ectopic pregnancy. Concern for fetal exposure to ionizing radiation is an important consideration in triage to imaging. Serum &beta;-hCG test becomes positive about 9 days after conception. Thus, a negative serum &beta;-hCG test essentially excludes the diagnosis of a live intrauterine pregnancy and acute ectopic pregnancy. Some studies suggest that in a pregnant patient endometrial thickness of &gt;21 mm virtually excludes the possibility of ectopic pregnancy. Literature from the 1980s correlated the presence of a gestational sac using TVS with &beta;-hCG levels of 1000 to 2000 mIU/mL. The sonographic detection of a normal intrauterine pregnancy at &beta;-hCG levels &gt;2000 mIU/mL can be complicated by variation in operator technique or obscuration of the endometrial cavity by fibroids, hemorrhage, intrauterine devices, or vaginal bleeding.</p>
<p>Current studies suggest that sometimes the gestational sac may not be visible on TVS until the &beta;-hCG level reaches 3510 mIU/mL. Therefore, in a stable patient the diagnosis of failed or ectopic pregnancy should not be made below this level, and repeat sonographic evaluation and &beta;-hCG levels should be obtained. The absence of an intrauterine pregnancy when the &beta;-hCG level is above the discriminatory zone of 3510 mIU/mL should be strongly suggestive of an ectopic pregnancy. The high specificity of adnexal findings suggestive of ectopic pregnancy, including the classic "tubal ring," has been widely reported in the literature. Endovaginal ultrasound (US) is currently considered the single best diagnostic modality to assess for ectopic pregnancy.</p>
<p><strong>Ultrasound</strong></p>
<p>Pelvic US is the initial study of choice in most reproductive-age women presenting with acute pelvic pain. TVS should be used whenever possible, although TAS is recommended when a larger field of view is desired, such as when uterine and adnexal structures are beyond the field of view of the transvaginal probe. In addition, duplex and color or power Doppler imaging can be used to characterize vascularity of the ovaries and the adnexal structures, information that may be helpful in narrowing the field of differential considerations. However, Doppler imaging should be avoided in the setting of developing intrauterine pregnancy and should be performed in a pregnant patient only when absolutely necessary.</p>
<p>In the evaluation of obstetrical and gynecological causes of pain, TVS may be able to differentiate findings such as hemorrhagic cyst or pelvic inflammatory disease, which are more compatible with medical management, from those that require emergency care, such as ovarian torsion (a surgical emergency) or obstetrical causes, including ectopic pregnancy or placental abruption, that may require urgent management. A hemorrhagic cyst may be hyperechoic acutely, but with hemolysis and retraction of the clot, a reticular network (sponge-like appearance) of fibrin stranding may be seen. Fluid-fluid levels between fluid components and a seemingly solid area representing retracted clot with concave outer margins may be demonstrated. Fibrin strands and a retracting clot are key observations in that they permit a confident diagnosis of hemorrhagic ovarian cysts. About 90% of hemorrhagic ovarian cysts will exhibit at least one of these two features. The specificity for diagnosis of a hemorrhagic cyst is 98.7%. Peripheral low-impedance flow without internal color Doppler signal is characteristic. Free fluid in the pelvis can be an indicator of cyst rupture. Hemoperitoneum can appear as fluid with low-level internal echoes.</p>
<p>Uncomplicated pelvic inflammatory disease may not be demonstrated sonographically, although early acute signs such as thickening of the fallopian tube or increased vascularity can be seen in a targeted examination. Salpingitis can present as a solid adnexal mass or a cystic paraovarian mass with a thick wall and increased vascularity. A tubo-ovarian abscess (TOA) is an inflammatory mass that involves the ovary, fallopian tube, and sometimes adjacent pelvic organs such as the bowel and bladder. Clumping of these structures together is called a tubo-ovarian complex. The sensitivity for the diagnosis of TOA by US ranges from 56% to 93%, with a specificity of 86% to 98%. The sonographic findings for TOA are nonspecific. The presence of a mass in the expected location of the ovaries or in the cul-de-sac, associated with elevated white cell count, erythrocyte sedimentation rate, and clinical suspicion, is important in making the correct diagnosis. US guidance can be used to drain a TOA and may help preserve fertility.</p>
<p>The most consistent finding of torsion is an enlarged edematous ovary or ovarian complex consisting of an ovary with an associated adnexal mass. One study in menarchal females suggests that an adnexal volume of &lt;20 mL precludes torsion. Another feature suggestive of torsion is peripherally placed follicles in an enlarged ovary; however, this finding can also be seen in a polycystic ovary. Findings on Doppler vary, including absent, decreased, or reversed ovarian artery flow, and may depend on the degree of obstruction and chronicity. Lack of Doppler flow enables fairly confident diagnosis, but the presence of arterial and venous Doppler signal has been documented in one-third of cases with surgically proven torsion. More recently, a study has appeared in the literature demonstrating an abnormal flow pattern within the ovarian vein as the only Doppler finding in patients with early torsion, lending support for Doppler findings associated with the diagnosis. One study reported sensitivities and specificities for diagnosis of ovarian torsion based on the following findings: tissue edema, 21% and 100%; absence of intraovarian vascularity, 52% and 91%; absence of arterial flow, 76% and 99%; and absence or abnormal venous flow, 100% and 97%, respectively. However, the reliability of this finding needs further investigation. Other signs suggestive of ovarian torsion are the whirlpool sign and the twisted-pedicle sign.</p>
<p>Sonography should be considered when gastrointestinal or urinary tract pathology is suspected in pregnant patients. Despite some diagnostic limitations, sonography has the advantage over CT because the latter uses ionizing radiation. In the diagnosis of appendicitis, TAS has demonstrated variable sensitivity (67% to 100%) and specificity (83% to 96%). Unfortunately, the technique of graded compression required for this diagnosis may not be feasible in the presence of an enlarged, gravid uterus. More importantly, a normal appendix is visualized in as few as 13% to 50% patients, even in the absence of pregnancy. As a result, a negative US examination cannot exclude the diagnosis of appendicitis. For diagnosis of obstructing ureteral calculi, a wide range of sensitivities (34% to 95%) has been reported with US. In a pregnant patient, US may not be able to differentiate physiologic hydronephrosis from obstructive hydronephrosis and may result in unnecessary surgical intervention. Early ureteral obstruction by a small calculus may not be associated with pelvocaliectasis, resulting in a false-negative examination.</p>
<p><strong>Computed Tomography</strong></p>
<p>CT provides the best diagnostic performance in identifying the gastrointestinal and urinary tract causes of acute pelvic pain. It shows high sensitivity (95% to 100%) and specificity (87% to 98%) in diagnosing appendicitis. CT is superior to US because it decreases the likelihood of false-negative laparotomy. Because CT almost always permits a normal appendix to be visualized, it is useful for reliably excluding the diagnosis of appendicitis. CT is also the preferred modality for detecting other bowel pathologies, such as inflammatory bowel disease, diverticulitis, and infectious enteritis or colitis. CT without intravenous contrast is more sensitive than sonography for detecting ureteral calculi, with a reported sensitivity of 96% and specificity of 93% to 98%. Low-dose noncontrast CT is routinely used in the detection of pain on the basis of suspected renal colic. If CT is to be performed, low-dose noncontrast CT for acute pelvic pain in pregnancy has been suggested to reduce radiation exposure, particularly in the second and third trimester. In children and young adults, the scanning technique can be modified to minimize the radiation dose without significantly compromising accuracy. Newer technology such as dual-energy CT has the capability to mathematically create virtually unenhanced images from contrast-enhanced images and is able to characterize the chemical composition of renal calculi. This technique can especially be used in nonpregnant patients to help in treatment planning.</p>
<p>For accurate diagnosis of pyelonephritis, pelvic venous thrombosis, ovarian vein thrombus, and most bowel pathologies, intravenous contrast-enhanced CT is required for optimum accuracy. For the diagnosis of acute appendicitis on CT, clinical practice is trending against the administration of enteric contrast, in particular, rectal contrast, when intravenous contrast will be administered. Two studies suggest that for diagnosis of appendicitis or other acute abdominal processes, administration of intravenous contrast alone yields similar results to administration of oral, rectal, and intravenous contrast. Another suggests that neutral versus positive oral contrast does not change the diagnostic accuracy. Although the addition of oral contrast has been shown to provide additional diagnostic confidence in a minority of patients, the routine use of oral contrast is associated with increased examination time and concerns with patient tolerance.</p>
<p>CT is often the first-line imaging modality in the diagnosis of abdominal pain originating from bowel, the urinary tract, or gynecologic pathology. CT findings of ovarian torsion are well documented in the literature and include a twisted vascular pedicle, thickening of the fallopian tube, smooth-walled thickening of a cystic adnexal mass, ascites, uterine deviation to the twisted side, and infiltration of adjacent pelvic fat. CT may allow better appreciation of mild inflammatory changes compared to US, with one study reporting the diagnostic accuracy of CT for acute salpingitis to be 84%. Acute pelvic pain can occur following rupture of a corpus luteal cyst or an endometrioma. The partially collapsed corpus luteal cyst has a crenulated or redundant wall on CT, whereas endometrial cysts are multilocular and usually larger compared to corpus luteal cysts.</p>
<p><strong>Magnetic Resonance Imaging</strong></p>
<p>MRI is a useful problem-solving tool in the evaluation of pelvic pain in pregnant women. When available, MRI is preferred to CT because it lacks ionizing radiation. In the diagnosis of appendicitis in pregnancy, MRI has high sensitivity and specificity (80% to 100% and 94% to 100%, respectively) using single-shot fast spin-echo and half-Fourier single-shot turbo spin-echo sequences. MRI can permit visualization of a normal appendix in approximately 83% to 90% of patients, and preclude negative appendectomies and may replace CT in the future. In a direct comparison of US to MRI in women suspected of appendicitis, a normal appendix was identified in 2% versus 87%, respectively.</p>
<p>MR urography without contrast reliably detects hydroureteronephrosis with a sensitivity and specificity of 95% and 100%, respectively, and is considered to be useful when US is nondiagnostic in pregnant patients. Obstruction secondary to urinary tract calculus can be distinguished from physiologic dilatation of pregnancy because renal enlargement and perinephric fluid from pyelosinus backflow are found only when there is pathology. However, MR lacks sensitivity for detecting small ureteral stones. False-positive findings from flow artifacts may simulate stones.</p>
<p>Gadolinium-based contrast agents cross the placenta; however, they have not been shown to cause any adverse effects in human fetuses when clinically recommended doses have been used. In one study, pregnant patients who received gadolinium contrast agents in the first trimester of pregnancy demonstrated no evidence of teratogenic effects in their children. Although the limited available literature suggests it is unlikely that gadolinium would have an adverse effect on fetal development, it is prudent to exercise caution and use contrast-enhanced MR imaging only when it can critically change the diagnosis. Currently there are several techniques which can evaluate the venous system in a pregnant female without intravenous contrast. MR venography can be used effectively to diagnose pelvic deep-vein thrombosis and is considered better than US. For gynecologic pathologies, there is some evidence that MRI may be more accurate than TVS in diagnosing pelvic inflammatory disease if Doppler US is not performed. The addition of diffusion-weighted MRI to conventional MRI may improve the diagnostic accuracy for pelvic inflammatory disease. The imaging findings of ovarian torsion on CT and MRI are almost similar. CT and MRI both can show abnormal or absent ovarian enhancement along with a subacute hematoma.</p>
<p><strong>Summary of Recommendations</strong></p>
<ul style="list-style-type: disc;">
    <li>Acute pelvic pain in the reproductive age group presents a diagnostic challenge. US, CT, and MRI often playing an integral role in arriving at the correct diagnosis. The choice of the correct imaging test depends on the results of a careful clinical evaluation in order to narrow the differential diagnosis. Measuring the serum &beta;-hCG level is the first step. TVS is the imaging procedure of choice to locate a pregnancy (assess the possibility of an ectopic versus intrauterine pregnancy) and the status of the fetus. TVS can sometimes distinguish malignant from benign ovarian masses and has a specificity of 98.7% in diagnosing a hemorrhagic cyst. TVS is the modality of choice in suspected pain from gynecologic origin. TVS with Doppler is useful in the diagnosis of ovarian torsion. CT performs well in the diagnosis of nongynecologic etiologies of acute pelvic pain. CT has a high sensitivity and specificity in the diagnosis of obstructive uropathy and appendicitis. CT is the preferred modality to assess diverticulitis, enteritis, and colitis. MRI can be used as a problem-solving tool in pregnant patients, and it has a high sensitivity and specificity in diagnosing appendicitis in this cohort. </li>
    <li>In a pregnant patient without acute signs of infection (please refer to ACR practice guidelines in pregnant patients) and with a suspected gynecologic etiology for pain, a pelvic US with adnexal Doppler would be the initial modality to assess the etiology. If the US is inconclusive, then MRI without contrast can be done for further evaluation. In a pregnant patient with suspected nongynecologic etiology for pain, US may be helpful but potentially challenging, particularly in the latter half of pregnancy. MRI is the most sensitive modality if appendicitis is suspected. The best modality to assess for renal calculi is a low-dose noncontrast CT. The addition of oral contrast to CT may help in diagnosing appendicitis, enteritis, colitis, or diverticulitis. </li>
    <li>In a nonpregnant patient presenting with abdominal pain and a suspected gynecologic etiology with no clinical signs of infection, US is the best initial modality. If inconclusive, the next best modality is contrast-enhanced MRI, followed by contrast-enhanced CT. If an infectious etiology is suspected, the best modality in a female of childbearing age is contrast-enhanced MRI. </li>
    <li>In a nonpregnant patient with pain suspected from a nongynecologic origin, a contrast-enhanced CT is the imaging modality of choice. In certain situations, dual-energy CT can be used and virtually unenhanced CT images reconstructed to assess for renal calculi. To avoid radiation exposure in a patient of childbearing age, MRI can be considered but is less sensitive for identification of small calculi with mild or early ureteral obstruction. </li>
    <li>The suspected etiology of the acute pelvic pain, whether it is obstetrical, gynecological, gastrointestinal, or urinary, will determine which pelvic imaging modality is the most appropriate for accurate and expeditious diagnosis and triage. </li>
</ul>
<strong>Abbreviations</strong>
<ul style="list-style-type: disc;">
    <li>CT, computed tomography </li>
    <li>&beta;-hCG, beta-human chorionic gonadotropin </li>
    <li>MRI, magnetic resonance imaging </li>
    <li>US, ultrasound </li>
</ul>
<p><strong>Relative Radiation Level Designations</strong></p>
<table width="50%" border="1" cellspacing="3" cellpadding="5" summary="Table: Relative Radiation Level Designations">
    <thead>
        <tr>
            <th class="Center" valign="top">Relative Radiation Level*</th>
            <th class="Center" valign="top">Adult Effective Dose Estimate Range</th>
            <th class="Center" valign="top">Pediatric Effective Dose Estimate Range</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td class="Center" valign="top">O</td>
            <td class="Center" valign="top">0 mSv</td>
            <td class="Center" valign="top">0 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td class="Center" valign="top">&lt;0.1 mSv</td>
            <td class="Center" valign="top">&lt;0.03 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td class="Center" valign="top">0.1-1 mSv</td>
            <td class="Center" valign="top">0.03-0.3 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td class="Center" valign="top">1-10 mSv</td>
            <td class="Center" valign="top">0.3-3 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td class="Center" valign="top">10-30 mSv</td>
            <td class="Center" valign="top">3-10 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive" src="https://web.archive.org/web/20180712204238im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td class="Center" valign="top">30-100 mSv</td>
            <td class="Center" valign="top">10-30 mSv</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <td valign="top" colspan="3">*RRL assignments for some of the examinations cannot be made, because the actual patient doses in these procedures vary as a function of a number of factors (e.g., region of the body exposed to ionizing radiation, the imaging guidance that is used). The RRLs for these examinations are designated as "Varies."</td>
    </tr>
    </tfoot>
</table></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>Algorithms were not developed from criteria guidelines.</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Acute pelvic pain</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Diagnosis</p>
                    <p>Evaluation</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Family Practice</p>
                    <p>Gastroenterology</p>
                    <p>Internal Medicine</p>
                    <p>Obstetrics and Gynecology</p>
                    <p>Radiology</p>
                    <p>Urology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Health Plans</p>
                    <p>Hospitals</p>
                    <p>Managed Care Organizations</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                    <p>Students</p>
                    <p>Utilization Management</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To evaluate the appropriateness of imaging modalities for differential diagnosis of acute pelvic pain in the reproductive age group</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Female patients in the reproductive age group with acute pelvic pain</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><ol style="list-style-type: decimal;">
    <li>Ultrasound (US)
    <ul style="list-style-type: disc;">
        <li>Pelvis, transvaginal </li>
        <li>Pelvis, transabdominal </li>
        <li>Abdomen and pelvis, transabdominal </li>
        <li>Duplex Doppler, adnexa </li>
        <li>Duplex Doppler, pelvis </li>
    </ul>
    </li>
    <li>Magnetic resonance imaging (MRI)
    <ul style="list-style-type: disc;">
        <li>Pelvis, without contrast </li>
        <li>Pelvis, without and with contrast </li>
        <li>Abdomen and pelvis, without contrast </li>
        <li>Abdomen and pelvis, without and with contrast </li>
    </ul>
    </li>
    <li>Computed tomography (CT)
    <ul style="list-style-type: disc;">
        <li>Pelvis, without contrast </li>
        <li>Pelvis, with contrast </li>
        <li>Pelvis, without and with contrast </li>
        <li>Abdomen and pelvis, without contrast </li>
        <li>Abdomen and pelvis, with contrast </li>
        <li>Abdomen and pelvis, without and with contrast </li>
    </ul>
    </li>
</ol></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Utility of imaging modalities in the differential diagnosis of acute pelvic pain </li>
    <li>Sensitivity and specificity of imaging modalities in the differential diagnosis of acute pelvic pain </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Literature Search Summary</span></strong></p>
<p>Of the 41 citations in the original bibliography, 37 were retained in the final document. Articles were removed from the original bibliography if they were more than 10 years old and did not contribute to the evidence or they were no longer cited in the revised narrative text.</p>
<p>A new literature search was conducted in December 2013 to identify additional evidence published since the <em>ACR Appropriateness Criteria&reg; Acute Pelvic Pain in the Reproductive Age Group</em> topic was finalized. Using the search strategy described in the literature search companion (see the "Availability of Companion Documents" field), 36 articles were found. Seven articles were added to the bibliography. Twenty-nine articles were not used due to either poor study design, the articles were not relevant or generalizable to the topic, the results were unclear, misinterpreted, or biased, or the articles were already cited in the original bibliography.</p>
<p>The author added 43 citations from bibliographies, Web sites, or books that were not found in the new literature search.</p>
<p>Four citations are supporting documents that were added by staff.</p>
<p>See also the American College of Radiology (ACR) Appropriateness Criteria&reg; literature search process document (see the "Availability of Companion Documents" field) for further information.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Of the 41 citations in the original bibliography, 37 were retained in the final document. The new literature search conducted in December 2013 identified 7 articles that were added to the bibliography. The author added 43 citations from bibliographies, Web sites, or books that were not found in the new literature search. Four citations are supporting documents that were added by staff.</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Definitions of Study Quality Categories</span></strong></p>
<p>Category 1 - The study is well-designed and accounts for common biases.</p>
<p>Category 2 - The study is moderately well-designed and accounts for most common biases.</p>
<p>Category 3 - The study has important study design limitations.</p>
<p>Category 4 - The study or source is not useful as primary evidence. The article may not be a clinical study, the study design is invalid, or conclusions are based on expert consensus.</p>
<p class="Indent">The study does not meet the criteria for or is not a hypothesis-based clinical study (e.g., a book chapter or case report or case series description);</p>
<p class="Indent"><em>Or</em></p>
<p class="Indent">The study may synthesize and draw conclusions about several studies such as a literature review article or book chapter but is not primary evidence;</p>
<p class="Indent"><em>Or</em></p>
<p class="Indent">The study is an expert opinion or consensus document.</p>
<p>Category M - Meta-analysis studies are not rated for study quality using the study element method because the method is designed to evaluate individual studies only. An "M" for the study quality will indicate that the study quality has not been evaluated for the meta-analysis study.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Review of Published Meta-Analyses</p>
                    <p>Systematic Review with Evidence Tables</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>The topic author assesses the literature then drafts or revises the narrative summarizing the evidence found in the literature. American College of Radiology (ACR) staff drafts an evidence table based on the analysis of the selected literature. These tables rate the study quality for each article included in the narrative.</p>
<p>The expert panel reviews the narrative, evidence table and the supporting literature for each of the topic-variant combinations and assigns an appropriateness rating for each procedure listed in the variant table(s). Each individual panel member assigns a rating based on his/her interpretation of the available evidence.</p>
<p>More information about the evidence table development process can be found in the ACR Appropriateness Criteria&reg; Evidence Table Development document (see the "Availability of Companion Documents" field).</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus (Delphi)</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Rating Appropriateness</span></strong></p>
<p>The American College of Radiology (ACR) Appropriateness Criteria (AC) methodology is based on the RAND/UCLA Appropriateness Method. The appropriateness ratings for each of the procedures or treatments included in the AC topics are determined using a modified Delphi method. An initial survey is conducted to elicit each panelist's expert interpretation of the evidence, based on the available data, regarding the appropriateness of an imaging or therapeutic procedure for a specific clinical scenario. The expert panel members review the evidence presented and assess the risks or harms of doing the procedure balanced with the benefits of performing the procedure. The direct or indirect costs of a procedure are not considered as a risk or harm when determining appropriateness (additional assumptions regarding rating appropriateness can be found in the document <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRatingRoundInfo.pdf" title="ACR Web site">Rating Round Information</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>). When the evidence for a specific topic and variant is uncertain or incomplete, expert opinion may supplement the available evidence or may be the sole source for assessing the appropriateness.</p>
<p>The appropriateness is represented on an ordinal scale that uses integers from 1 to 9 grouped into three categories: 1, 2, or 3 are in the category "usually not appropriate" where the harms of doing the procedure outweigh the benefits; and 7, 8, or 9 are in the category "usually appropriate" where the benefits of doing a procedure outweigh the harms or risks. The middle category, designated "may be appropriate," is represented by 4, 5, or 6 on the scale. The middle category is when the risks and benefits are equivocal or unclear, the dispersion of the individual ratings from the group median rating is too large (i.e., disagreement), the evidence is contradictory or unclear, or there are special circumstances or subpopulations which could influence the risks or benefits that are embedded in the variant.</p>
<p>The ratings assigned by each panel member are presented in a table displaying the frequency distribution of the ratings without identifying which members provided any particular rating. To determine the panel's recommendation, the rating category that contains the median group rating without disagreement is selected. This may be determined after either the first or second rating round. If there is disagreement after the first rating round, a conference call is scheduled to discuss the evidence and, if needed, clarify the variant or procedure description. If there is still disagreement after the second rating round, the recommendation is "may be appropriate."</p>
<p>This modified Delphi method enables each panelist to articulate his or her individual interpretations of the evidence or expert opinion without excessive influence from fellow panelists in a simple, standardized, and economical process. For additional information on the ratings process see the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRatingRoundInfo.pdf" title="ACR Web site">Rating Round Information</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> document.</p>
<p>Additional methodology documents, including a more detailed explanation of the complete topic development process and all ACR AC topics can be found on the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2fQuality-Safety%2fAppropriateness-Criteria" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> (see also the "Availability of Companion Documents" field).</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p>Not applicable</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.<br/>
</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>Criteria developed by the Expert Panels are reviewed by the American College of Radiology (ACR) Committee on Appropriateness Criteria (AC).</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The recommendations are based on analysis of the current medical evidence literature and the application of the RAND/UCLA appropriateness method and expert panel consensus.</p>
<p><strong><span style="text-decoration: underline;">Summary of Evidence</span></strong></p>
<p>Of the 91 references cited in the <em>ACR Appropriateness Criteria&reg; Acute Pelvic Pain in the Reproductive Age Group</em> document, 87 are categorized as diagnostic references including 6 well designed studies, 10 good quality studies, and 32 quality studies that may have design limitations. Additionally, 1 reference is categorized as a good quality therapeutic study. There are 39 references that may not be useful as primary evidence. There are 3 references that are meta-analysis studies.</p>
<p>While there are references that report on studies with design limitations, 17 well designed or good quality studies provide good evidence.</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>Appropriate selection of radiologic imaging procedures to evaluate female patients in the reproductive age group with acute pelvic pain</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>In a pregnant patient, ultrasound (US) may not be able to differentiate physiologic hydronephrosis from obstructive hydronephrosis and may result in unnecessary surgical intervention. Early ureteral obstruction by a small calculus may not be associated with pelvocaliectasis, resulting in a false-negative examination. </li>
    <li>Magnetic resonance (MR) lacks sensitivity for detecting small ureteral stones. False-positive findings from flow artifacts may simulate stones. </li>
    <li>Although the limited available literature suggests it is unlikely that gadolinium would have an adverse effect on fetal development, it is prudent to exercise caution and use contrast-enhanced MR imaging only when it can critically change the diagnosis. </li>
</ul>
<p>Refer to the "Safety Considerations in Pregnant Patients" section of the original guideline document for a list of American College of Radiology (ACR) documents regarding imaging of pregnant women.</p>
<p><strong><span style="text-decoration: underline;">Relative Radiation Level</span></strong></p>
<p>Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level (RRL) indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Patients in the pediatric age group are at inherently higher risk from exposure, both because of organ sensitivity and longer life expectancy (relevant to the long latency that appears to accompany radiation exposure). For these reasons, the RRL dose estimate ranges for pediatric examinations are lower as compared to those specified for adults. Additional information regarding radiation dose assessment for imaging examinations can be found in the ACR Appropriateness Criteria&reg; Radiation Dose Assessment Introduction document (see the "Availability of Companion Documents" field).</p></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>The American College of Radiology (ACR) Committee on Appropriateness Criteria (AC) and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists, and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient's clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient's condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the U.S. Food and Drug Administration (FDA) have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination. </li>
    <li>ACR seeks and encourages collaboration with other organizations on the development of the ACR AC through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply individual or society endorsement of the final document. </li>
</ul></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Getting Better</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Safety</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Bhosale PR, Atri M, Harris RD, Kang SK, Meyer BJ, Pandharipande PV, Reinhold C, Salazar GM, Shipp TD, Simpson L, Sussman BL, Uyeda J, Wall DJ, Zelop CM, Javitt MC, Glanc P, Expert Panel on Women’s Imaging. ACR Appropriateness Criteria® acute pelvic pain in the reproductive age group. Reston (VA): American College of Radiology (ACR); 2015. 13 p.  [91 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2015</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>American College of Radiology - Medical Specialty Society</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>The American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria&reg;.</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Committee on Appropriateness Criteria, Expert Panel on Women's Imaging</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Panel Members</em>: Priyadarshani R. Bhosale, MD (<em>Principal Author</em>); Mostafa Atri, MD; Robert D. Harris, MD, MPH; Stella K. Kang, MD, MS; Benjamin J. Meyer, MD; Pari V. Pandharipande, MD, MPH; Caroline Reinhold, MD; Gloria M. Salazar, MD; Thomas D. Shipp, MD, RDMS; Lynn Simpson, MD; Betsy L. Sussman, MD; Jennifer Uyeda, MD; Darci J. Wall, MD; Carolyn M. Zelop, MD; Marcia C. Javitt, MD (<em>Specialty Chair</em>); Phyllis Glanc, MD (<em>Panel Chair</em>)</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Andreotti RF, Lee SI, DeJesus Allison SO, Bennett GL, Brown DL, Dubinsky T, Glanc P, Javitt MC, Mitchell DG, Podrasky AE, Shipp TD, Siegel CL, Wong-You-Cheong JJ, Zelop CM, Expert Panel on Women's Imaging. ACR Appropriateness Criteria&reg; acute pelvic pain in the reproductive age group. [online publication]. Reston (VA): American College of Radiology (ACR); 2011. 8 p. [51 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f69503%2fNarrative" title="ACR Web site">American College of Radiology (ACR) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>ACR Appropriateness Criteria&reg;. Overview. Reston (VA): American College of Radiology; 2015 Oct. 3 p. Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fOverview.pdf" title="ACR Web site">American College of Radiology (ACR) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Literature search process. Reston (VA): American College of Radiology; 2015 Feb. 1 p. Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fLiteratureSearchProcess.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Evidence table development. Reston (VA): American College of Radiology; 2015 Nov. 5 p. Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fEvidenceTableDevelopment.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Topic development process. Reston (VA): American College of Radiology; 2015 Nov. 2 p. Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fTopicDevelopmentProcess.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Rating round information. Reston (VA): American College of Radiology; 2015 Apr. 5 p. Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRatingRoundInfo.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Radiation dose assessment introduction. Reston (VA): American College of Radiology; 2015 Sep. 3 p. Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRadiationDoseAssessmentIntro.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Procedure information. Reston (VA): American College of Radiology; 2015 Jul; 2 p. Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fProcedureInfo.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Manual on contrast media. Reston (VA): American College of Radiology; 2015; 129 p. Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2fQuality-Safety%2fResources%2fContrast-Manual" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg; acute pelvic pain in the reproductive age group. Evidence table. Reston (VA): American College of Radiology; 2015. 26 p. Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f69503%2fET" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg; acute pelvic pain in the reproductive age group. Literature search. Reston (VA): American College of Radiology; 2015. 1 p. Available from the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f69503%2fLitSearch%2f" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on June 14, 2010. This summary was updated by ECRI Institute on January 13, 2011 following the U.S. Food and Drug Administration (FDA) advisory on gadolinium-based contrast agents. This summary was updated by ECRI Institute on August 30, 2011. This summary was updated by ECRI Institute on February 12, 2016.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>Instructions for downloading, use, and reproduction of the American College of Radiology (ACR) Appropriateness Criteria&reg; may be found on the <a href="/web/20180712204238/https://www.guideline.gov/Home/Disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2fQuality-Safety%2fAppropriateness-Criteria%2fTermsConditions" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204238im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712204238/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712204238/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712204238/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712204238/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712204238/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712204238/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712204238/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204238/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204238/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204238/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204238/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204238/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712204238/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712204238/https://www.guideline.gov/disclaimer?id=49922&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712204238im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712204238im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712204238/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712204238/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712204238/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712204238/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712204238/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712204238/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712204238/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712204238/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712204238/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712204238/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712204238/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712204238/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712204238/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712204238/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712204238/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712204238/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712204238/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712204238/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712204238/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712204238im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712204238im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712204238/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712204238im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712204238im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712204238/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712204238/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712204238js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712204238js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 20:42:38 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:23:58 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 494.373 (3)
  esindex: 0.112
  captures_list: 521.842
  CDXLines.iter: 15.409 (3)
  PetaboxLoader3.datanode: 205.416 (4)
  exclusion.robots: 0.291
  exclusion.robots.policy: 0.272
  RedisCDXSource: 6.41
  PetaboxLoader3.resolve: 790.813 (2)
  load_resource: 621.336
-->